DIRS.INFO The most relevant business & tech news

☆ Intra-Africa trade could double in next five years, says Secretary General of African Continental Free Trade Area
▼ + stars: | 2024-10-07 | by ( Nell Lewis | ) edition.cnn.com time to read: +8 min

CNN —Africa is home to the world’s largest free trade agreement, in terms of number of countries, territory, and population – the African Continental Free Trade Area (AfCFTA). According to the Economic Commision for Africa, African countries continue to trade with the rest of the world more than among themselves. Aliko Dangote has been talking about the fact that he needs 35 visas to travel across the African continent. WM: It’s a significant barrier and constraint to intra-Africa trade and intra-Africa investment. I think we can double intra-Africa trade in the next five years, provided we introduce the tools that are required.

Persons: CNN’s Eleni Giokos, Wamkele Mene, Eleni Giokos, Wamkele, it’s, Mene, Aliko Dangote, It’s, I’ve, it’ll Organizations: CNN, Continental Free Trade Area, Union, EG, Continental Free Trade, CNN EG, African Continental Free Trade Area, European Union, Africa can’t, Democratic Locations: Africa, Kigali, Rwanda, Angola, Zambia, Democratic Republic of Congo, Central Africa, Eastern Africa, Northern Africa, –

☆ Autonomous Cars Beat EVs
▼ + stars: | 2023-11-19 | by ( Andy Kessler | ) www.wsj.com time to read: +1 min

Journal Editorial Report: The week’s best and worst from Bill McGurn, Kate Bachelder Odell, Mene Ukueberuwa, and Kim Strassel. And given high prices for EVs, subsidies are mainly a giveaway to the already well-off. If you add up carbon emissions from manufacturing, daily use and end of life, EVs have total life-cycle emissions 30% lower than gasoline-powered autos. In Silicon Valley, something is considered truly transformational if it’s 10 times better, not a third. Instead of throwing taxpayer money at EVs, President Biden could have been a hero and helped bring autonomous vehicles to the market faster.

Persons: Bill McGurn, Kate Bachelder Odell, Mene Ukueberuwa, Kim Strassel, Mark Kelly, Ford, Biden Organizations: Getty, Honda, General Motors Locations: Silicon, EVs

☆ U.S. CEOs on the Chinese Menu
▼ + stars: | 2023-11-17 | by ( The Editorial Board | ) www.wsj.com time to read: +1 min

Journal Editorial Report: The week’s best and worst from Bill McGurn, Kate Bachelder Odell, Mene Ukueberuwa, and Kim Strassel. Images: AFP/Getty Images/Reuters Composite: Mark KellyWhatever the merits of this week’s summit between President Biden and Chinese President Xi Jinping , there was no reason for U.S. business leaders to trip over themselves to get in on the action. Yet there they were Wednesday evening, kowtowing to Mr. Xi at a dinner that delivered China a propaganda coup and the CEOs an embarrassment. The dinner, for which ticket prices ranged up to $40,000, sounds like some affair. Mr. Xi received a standing ovation for taking the stage before he said a word.

Persons: Bill McGurn, Kate Bachelder Odell, Mene Ukueberuwa, Kim Strassel, Mark Kelly, Biden, Xi Jinping, kowtowing, Xi, Tim Cook Organizations: Getty, Qualcomm, Boeing, U.S Locations: China

☆ Trump University, Now With Tax Money
▼ + stars: | 2023-11-13 | by ( The Editorial Board | ) www.wsj.com time to read: +1 min

Journal Editorial Report: The week’s best and worst from Bill McGurn, Kate Bachelder Odell, Mene Ukueberuwa, and Kim Strassel. Images: AFP/Getty Images/Reuters Composite: Mark KellyAs if the federal bureaucracy didn’t have enough to do, Donald Trump says that in a second term he’d create a new tuition-free online university to “compete directly” for college students. It would award bachelor’s degree equivalents “that the U.S. government and all federal contractors will henceforth recognize.” Step right up to enroll in Trump University 2.0. Mr. Trump unveiled the idea recently in a video on Truth Social, and the plan includes all of the careful policy thinking typical of a video on Truth Social. “Whether you want lectures on ancient histories, or an introduction to financial accounting, or training in a skilled trade,” Mr. Trump said, “the goal will be to deliver it and get it done properly, using study groups, mentors, industry partnerships, and the latest breakthrough in computing.”

Persons: Bill McGurn, Kate Bachelder Odell, Mene Ukueberuwa, Kim Strassel, Mark Kelly, Donald Trump, Trump, Mr Organizations: Getty, Trump University

☆ The Best and Worst Dressed Senators
▼ + stars: | 2023-09-28 | by ( Joseph Epstein | ) www.wsj.com time to read: 1 min

Journal Editorial Report: The week's best and worst from Kim Strassel, Mene Ukueberuwa and Kyle Peterson. Images: AP/Getty Images/Zuma Press Composite: Mark KellyWhen I began teaching at Northwestern University half a century ago, I had to decide what to wear to work. Fifteen or so years before, the question would never have arisen. I would have worn a suit or sport jacket and pleated trousers, always a tie. That was before the 1960s, revolutionary in so many ways, including how professors could dress.

Persons: Kim Strassel, Mene Ukueberuwa, Kyle Peterson, Mark Kelly Organizations: Getty, Northwestern University

☆ AstraZeneca seeks to calm CEO speculation after shares drop
▼ + stars: | 2023-09-11 | by ( Maggie Fick | ) www.reuters.com time to read: +2 min

The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the New York Stock Exchange, U.S., April 8, 2019. The company initially declined to comment on the Mail on Sunday report, but later issued a statement saying: "We do not comment on market rumours. AstraZeneca shares closed down 3.2% after earlier touching their lowest since July 19. The Times' article focused on the retirement of Mene Pangalos, the long-time biopharmaceuticals head of research at AstraZeneca, which was announced in July. Reporting by Maggie Fick and Samuel Indyk; Editing by Tomasz Janowski and Mark PotterOur Standards: The Thomson Reuters Trust Principles.

Persons: Brendan McDermid, Pascal Soriot, Soriot, Mene Pangalos, Pangalos, Pascal, Maggie Fick, Samuel Indyk, Tomasz Janowski, Mark Potter Organizations: AstraZeneca, New York Stock Exchange, REUTERS, Reuters, Times, Thomson Locations: British

☆ AstraZeneca shares fall 4% to 7-1/2 week low
▼ + stars: | 2023-09-11 | by ( ) www.reuters.com time to read: +1 min

The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the New York Stock Exchange, U.S., April 8, 2019. REUTERS/Brendan McDermid/File Photo Acquire Licensing RightsCompanies AstraZeneca PLC FollowLONDON, Sept 11 (Reuters) - Shares in London-listed drugmaker AstraZeneca (AZN.L) fell more than 4% on Monday, sliding to their lowest since July 19. An AstraZeneca spokesperson declined to comment on the report. Two of the analysts and the shareholder also mentioned that an article published on Monday in Britain's Times newspaper could have affected the shares, though it appeared to contradict the Mail on Sunday report. The Times' article focused on the retirement of Mene Pangalos, the long-time biopharmaceuticals head of research at AstraZeneca, which was announced in July.

Persons: Brendan McDermid, Pascal Soriot, Mene Pangalos, Pangalos, Pascal, Maggie Fick, Samuel Indyk, Amanda Cooper, Tomasz Janowski Organizations: AstraZeneca, New York Stock Exchange, REUTERS, drugmaker's, Reuters, Britain's Times, Times, Thomson Locations: London

☆ Spinning Federal Mortgage Fees
▼ + stars: | 2023-04-28 | by ( The Editorial Board | ) www.wsj.com time to read: 1 min

Journal Editorial Report: The week's best and worst from Kim Strassel, Mene Ukueberuwa, Collin Levy and Dan Henninger. Images: AP/AFP/Getty Images/Zuma Press Composite: Mark KellyChanges to the Federal Housing Finance Agency’s mortgage pricing are creating a stir in the marketplace, not that the bureaucracy wants to admit it. The changes, which take effect Monday, raise costs for some good-credit borrowers while making mortgages cheaper for low-income borrowers. We highlighted the changes in a recent editorial, and FHFA Director Sandra Thompson objected to our characterization that the plan will socialize mortgage-lending risk. Ms. Thompson says the new policy “won’t impose higher fees on higher-credit-score borrowers than on lower-credit-score borrowers, all else equal.” She says some borrowers with higher credit scores may even pay less.

☆ The Pentagon Tilts at Windmills
▼ + stars: | 2023-04-26 | by ( The Editorial Board | ) www.wsj.com time to read: 1 min

Journal Editorial Report: The week's best and worst from Kim Strassel, Mene Ukueberuwa, Collin Levy and Dan Henninger. Witness how the Department of the Interior rolled over Pentagon warnings that offshore wind installations in the mid-Atlantic could interfere with military training. President Biden has set a goal of generating 30 gigawatts of offshore wind power by 2030. Waters off the coasts of North Carolina, Virginia, Maryland and Delaware are prime real estate for wind farms because they are relatively shallow. But they are also training grounds for the Navy and Air Force, including North Carolina’s Dare County bombing range.

☆ Et Tu, Juan? Clarence Thomas’s Fickle Friends Pile On
▼ + stars: | 2023-04-26 | by ( James Taranto | ) www.wsj.com time to read: +1 min

Journal Editorial Report: The week's best and worst from Kim Strassel, Mene Ukueberuwa, Collin Levy and Dan Henninger. Images: AP/AFP/Getty Images/Zuma Press Composite: Mark KellyMitt Romney once complained that Barack Obama didn’t play fair. “I’ve been disappointed in the president’s campaign to date, which is focused on character assassination,” he told reporters in May 2012. “If the reports are accurate, it stinks,” Mr. Romney said. “I don’t have to explain more than that.” But the reports contained many inaccuracies, as I documented last week.

☆ Biden Is Desperately Seeking Trump
▼ + stars: | 2023-04-26 | by ( The Editorial Board | ) www.wsj.com time to read: 1 min

Journal Editorial Report: The week's best and worst from Kim Strassel, Mene Ukueberuwa, Collin Levy and Dan Henninger. Images: AP/AFP/Getty Images/Zuma Press Composite: Mark KellyPresident Biden’s re-election announcement video on Tuesday was unusual, if not surprising. The early scenes are less about Mr. Biden’s record, and the sunny uplands of second-term hope, than they are about Donald Trump: images of the Jan. 6 riot, Trump signs, and a reference to “MAGA extremists.”The video betrays a little too obviously what Democrats and the press know but don’t like to admit in public: Mr. Biden desperately wants a rematch with Donald Trump. He doesn’t want to run on his own record. He wants to run one more time by stoking fear about what might happen if the former President returns to the Oval Office.

☆ Public Unions vs. the People
▼ + stars: | 2023-03-04 | by ( Mene Ukueberuwa | ) www.wsj.com time to read: 1 min

This copy is for your personal, non-commercial use only. Distribution and use of this material are governed by our Subscriber Agreement and by copyright law. For non-personal use or to order multiple copies, please contact Dow Jones Reprints at 1-800-843-0008 or visit www.djreprints.com. https://www.wsj.com/articles/the-people-vs-public-sector-unions-philip-howard-collective-bargaining-public-private-fdr-teddy-roosevelt-supreme-court-nyc-transit-pension-healthcare-7d1e45f4

☆ Eight killed in mass shooting at birthday party in South Africa
▼ + stars: | 2023-01-30 | by ( ) www.reuters.com time to read: +1 min

JOHANNESBURG, Jan 30 (Reuters) - Gunmen killed eight people and wounded three others at a birthday party in South Africa's Eastern Cape province, police said, adding that manhunt was underway to find the killers. The latest incident follows a spate of mass shootings last year that shocked the nation. In July, gunmen killed 19 people in random shootings within hours of each other. South Africa has one of the world's highest murder rates, with around 20,000 people killed every year out of a population of 60 million. According to campaign group Gun Free South Africa, there are about 3 million guns registered in the country, though there are many more unregistered.

☆ A portrait of one of the few young, female truckers in France
▼ + stars: | 2023-01-06 | by ( Jacqui Palumbo | ) edition.cnn.com time to read: +4 min

Amélie is one of the few female truck drivers in France. At the time photographer Yohanne Lamoulère met her in 2019, she was driving from Arles to Castellón, Spain, and back at least twice a week, Lamoulère explained over email. The photographer, whose uncle is also a trucker, met Amélie at a truck show in southeastern France where drivers decorate their vehicles for a competition. Lamoulère then shot her portrait of the newly-engaged couple in front of Amélie’s truck, the bouquet placed on the dashboard above their heads. She said it’s rare to see a young woman “aboard monsters like Amélie’s truck” and finds it “very beautiful” to see her forge her own path.

Persons: CNN —, Yohanne, Amélie Riquelme, Yohanne Lamoulère, Lamoulère, Jérémy, Amélie, “, ” Lamoulère, — Jérémy, Lucie, Les, qu’on Organizations: CNN, Volvo, International Road Transport Union, Cité Internationale des Arts Locations: Amélie, France, Arles, Europe, Castellón, Spain, Paris, Cité

BlackRock and other giant firms use your money to advance ESG ideas you may not agree with, even if you own index funds. Vivek Ramaswamy has brought an alternative to the market.

☆ ANUNŢUL făcut de AstraZeneca privind tratamentul său în cazul persoanelor expuse recent la noul coronavirus
▼ + stars: | 2021-06-15 | by ( Publika.Md - Aici Sunt Știrile | ) www.publika.md time to read: +2 min

Compania farmaceutică anglo-suedeză AstraZeneca a anunţat marţi că, în urma unui studiu clinic, tratamentul său bazat pe anticorpi monoclonali, AZD7442, nu şi-a atins obiectivul principal de prevenire a formelor simptomatice de COVID-19 în cazul persoanelor expuse recent la noul coronavirus, informează Reuters, citează Agerpres. AZD7442 a redus riscul de a dezvolta o formă simptomatică de COVID-19 cu 33% în comparaţie cu grupul placebo, ceea ce nu este semnificativ din punct de vedere statistic, a mai precizat compania. AstraZeneca analizează tratamentul şi într-un studiu cu pacienţi pre-expuşi, precum şi pentru prevenirea unor forme mai grave ale bolii. Tratamentul cu anticorpi monoclonali face parte dintr-o clasă de medicamente care imită anticorpii naturali pe care organismul îi produce pentru a lupta cu o infecţie. AstraZeneca a anunţat în martie semnarea unui contract cu guvernul american pentru furnizarea a jumătate de milion de doze de AZD7442.

Persons: Reuters, AZD7442, Eli Lilly, Celltrion, Vir, AstraZeneca Organizations: Regeneron Pharmaceuticals, Vir Biotechnology Inc Locations: Statele Unite, Portsmouth, New Hampshire, Statelor Unite, SUA

☆ ANUNŢUL făcut de AstraZeneca privind tratamentul său pe bază de anticorpi în cazul persoanelor expuse recent la noul coronavirus
▼ + stars: | 2021-06-15 | by ( Publika.Md - Aici Sunt Știrile | ) www.publika.md time to read: +2 min

☆ Studiu: Tratamentul AstraZeneca pe bază de anticorpi nu este eficient în prevenirea COVID-19
▼ + stars: | 2021-06-15 | by ( ) www.jurnal.md time to read: +1 min

Sursa foto: Getty ImagesStudiu: Tratamentul AstraZeneca pe bază de anticorpi nu este eficient în prevenirea COVID-19Un studiu clinic privind o terapie cu anticorpi împotriva COVID-19 dezvoltat de compania farmaceutică AstraZeneca a arătat că tratamentul nu este eficient, a anunțat compania. AZD7442 - o combinație de doi anticorpi monoclonali diferiți - nu a dovedit o reducere semnificativă a riscului de COVID-19 simptomatic după expunerea la virus. Potrivit companiei, la studiu au participat adulţi nevaccinaţi cu vârste de peste 18 ani, care au confirmat expunerea la o persoană infectată cu coronavirus în ultimele opt zile. AZD7442 a redus riscul de a dezvolta o formă simptomatică de COVID-19 cu 33% în comparaţie cu grupul placebo, ceea ce nu este semnificativ din punct de vedere statistic, a mai precizat compania. AstraZeneca a semnat în octombrie un acord cu producătorul contractant Lonza pentru a produce medicamentul pe bază de anticorpi în Portsmouth, New Hampshire, începând cu prima jumătate a anului 2021.

Persons: AZD7442, AstraZeneca Locations: Portsmouth, New Hampshire

☆ STUDIU SUA: Eficienţa vaccinului de la AstraZeneca redusă la 76%
▼ + stars: | 2021-03-25 | by ( Publika.Md - Aici Sunt Știrile | ) www.publika.md time to read: +2 min

Compania farmaceutică AstraZeneca a redus miercuri de la 79% la 76% eficienţa vaccinului său împotriva COVID-19 în actualizarea studiului din SUA după ce autorităţile americane i-au cerut o revizuire a datelor iniţiale, relatează EFE.Rezultatele, foarte asemănătoare cu cele originale, indică şi o eficienţă de 85% în cazurile simptomatice de COVID-19 în rândul celor cu vârsta de peste 65 de ani şi de 100% în cazurile grave ale bolii sau spitalizărilor, scrie agerpres.ro Studiul a fost realizat cu ajutorul a 32.449 de voluntari din SUA, Chile şi Peru care au primit ori două doze de vaccin AstraZeneca ori placebo.Într-un comunicat, vicepreşedintele executiv al AstraZeneca, Mene Pangalos, a afirmat că "analiza principală este consistentă cu analiza provizorie publicată anterior şi confirmă că vaccinul anti-COVID-19 este înalt eficient la adulţi, inclusiv la ce de peste 65 de ani".El a reiterat că AstraZeneca intenţionează să ceară autorităţilor americane autorizaţia în regim de urgenţă pentru a distribui vaccinul în această ţară.Luni, compania a anunţat că vaccinul său are o eficienţă de 79%, lucru considerat "încurajator" de Casa Albă.Totuşi, un grup independent de experţi ce consiliază Administraţia Biden şi-a exprimat preocuparea, semnalând că datele utilizate pentru studiu ar putea să nu fie actualizate şi a sesizat autorităţile în acest sens.Prin urmare, Institutul Naţional pentru Alergii şi Boli Infecţioase din SUA (NIAID), condus de doctorul Anthony Fauci, a cerut companiei AstraZeneca să lucreze împreună cu grupul de experţi "pentru a revizui datele de eficienţă şi a garanta că aceste cifre de eficienţă mai precise şi actualizate să fie publicate cât mai repede posibil".Săptămâna trecută ţări europene precum Germania, Franţa, Italia sau Spania au suspendat temporar utilizarea vaccinului de la AstraZeneca după detectarea unor cazuri de coagulare a sângelui la pacienţii care au primit acest vaccin.SUA au cumpărat 300 de milioane de doze de vaccin de la AstraZeneca, deşi utilizarea sa încă nu a fost autorizată, iar împreună cu dozele achiziţionate de la Pfizer, Moderna şi Johnson and Johnson au doze suficiente pentru a vaccina întreaga populaţie.Guvernul SUA are deja o rezervă de zeci de milioane de doze de vaccin de la AstraZeneca, în aşteptarea autorizării serului, iar săptămâna trecută a convenit să împărtă 2,5 milioane de doze cu Mexic şi 1,5 milioane cu Canada.

Persons: ., Biden, Anthony Fauci, Johnson Organizations: Johnson Locations: SUA, Chile, Peru, Germania, Franţa, Italia, Spania, AstraZeneca, Pfizer, Mexic, Canada

☆ Nou studiu realizat în SUA: Vaccinul AstraZeneca are o eficienţă 100% împotriva bolii severe şi a spitalizării
▼ + stars: | 2021-03-22 | by ( ) www.jurnal.md time to read: +4 min

Sursa foto: lci.frNou studiu realizat în SUA: Vaccinul AstraZeneca are o eficienţă 100% împotriva bolii severe şi a spitalizăriiVaccinul AstraZeneca are o eficienţă de 79% în prevenirea bolii simptomatice şi de 100% împotriva celei severe şi a spitalizării, potrivit unui studiu efectuat în SUA. Rezultatele unui amplu studiu din SUA au arătat că vaccinul împotriva coronavirusului dezvoltat de AstraZeneca şi Universitatea Oxford are o eficienţă de 79% în prevenirea bolilor simptomatice şi de 100% împotriva bolilor severe şi a spitalizării, relatează Mediafax citând CNBC. Prin comparaţie, vaccinul Moderna are o eficacitate mai mare de 94% în prevenirea coronavirusului, iar vaccinul Pfizer-BioNTech s-a dovedit a avea 95% eficienţă. AstraZeneca a declarat luni, într-un comunicat, că un consiliu independent care a analizat vaccinul său nu a identificat probleme de siguranţă legate de acesta. În special, vaccinul Oxford-AstraZeneca a avut o eficienţă de 80% în prevenirea coronavirusului la participanţii cu vârsta de peste 65 de ani.

Persons: AstraZeneca, Ann Falsey Organizations: Universitatea Oxford, Mediafax, Universităţii Locations: SUA, Germania, Franţa, Italia, Spania, Oxford, Europa, Rochester

☆ „Întâmplarea fericită” care a dus la 90% eficacitate a vaccinului anti-COVID de la Oxford
▼ + stars: | 2020-11-24 | by ( Publika.Md - Aici Sunt Știrile | ) www.publika.md time to read: +2 min

Vaccinul dezvoltat de Universitatea Oxford și AstraZeneca a atins un grad de eficacitate de 90% în timpul testelor clinice datorită unei întâmplări fericite: o eroare de dozaj la unii dintre participanți, relatează The Guardian. Cercetătorii au aununțat luni că vaccinul Oxford a avut o eficacitate globală de 70%, dar ar putea fi eficient în proporție de 90% atunci când este administrat cu o jumătate de doză inițial, urmată de o doză completă o lună mai târziu, scrie digi24.ro. „Motivul pentru care am avut o jumătate de doză este o întâmplare fericită”, a spus Mene Pangalos, vicepreședinte executiv pentru cercetare și dezvoltare la AstraZeneca. „Așa că ne-am întors și am verificat și am aflat că au subevaluat doza de vaccin la jumătate”, a spus Pangalos. Aproximativ 3.000 de persoane au primit jumătate din doză și apoi o doză completă, patru săptămâni mai târziu, datele arătând că 90% dintre participanțiau fost protejați de infecția cu COVID-19.

Persons: AstraZeneca, Guardian, Sarah Gilbert, Andrew Pollard Organizations: Universitatea Oxford, Oxford, Group, Agenția Locations: Oxford

Search resuls for: "Mene"

21 mentions found